Medicare and Medicaid Programs: Application by Accreditation Commission for Health Care for Continued CMS-Approval of Its Hospice Accreditation Program, 31068-31070 [2019-13901]
Download as PDF
31068
Federal Register / Vol. 84, No. 125 / Friday, June 28, 2019 / Notices
FEDERAL COMMUNICATIONS
COMMISSION
Federal Advisory Committee Act;
Communications Security, Reliability,
and Interoperability Council
Federal Communications
Commission.
ACTION: Notice of public meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice advises interested persons that
the Federal Communications
Commission’s (FCC or Commission)
Communications Security, Reliability,
and Interoperability Council (CSRIC) VII
will hold its first meeting.
DATES: July 19, 2019.
ADDRESSES: Federal Communications
Commission, Room TW–C305
(Commission Meeting Room), 445 12th
Street SW, Washington, DC 20554.
FOR FURTHER INFORMATION CONTACT:
Suzon Cameron, Designated Federal
Officer, (202) 418–1916 (voice) or
Suzon.cameron@fcc.gov (email); or, Guy
Benson, Deputy Designated Federal
Officer, (202) 418–2946 (voice) or
guy.benson@fcc.gov (email).
SUPPLEMENTARY INFORMATION: The
meeting will be held on July 19, 2019,
from 1:00 p.m. to 5:00 p.m. in the
Commission Meeting Room of the
Federal Communications Commission,
Room TW–C305, 445 12th Street SW,
Washington, DC 20554.
The CSRIC is a Federal Advisory
Committee that will provide
recommendations to the FCC regarding
best practices and actions the FCC can
take to help ensure the security,
reliability, and interoperability of
communications systems. On March 15,
2019, the FCC, pursuant to the Federal
Advisory Committee Act, renewed the
charter for the CSRIC for a period of two
years through March 14, 2021. The
meeting on July 19, 2019, will be the
first meeting of the CSRIC under the
current charter. The FCC will attempt to
accommodate as many attendees as
possible; however, admittance will be
limited to seating availability. The
Commission will provide audio and/or
video coverage of the meeting over the
internet from the FCC’s web page at
https://www.fcc.gov/live. The public may
submit written comments before the
meeting to Suzon Cameron, CSRIC
Designated Federal Officer, by email
suzon.cameron@fcc.gov or U.S. Postal
Service Mail to Suzon Cameron, Senior
Attorney, Cybersecurity and
Communications Reliability Division,
Public Safety and Homeland Security
Bureau, Federal Communications
khammond on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:41 Jun 27, 2019
Jkt 247001
Commission, 445 12th Street SW, Room
7–B458, Washington, DC 20554.
Open captioning will be provided for
this event. Other reasonable
accommodations for people with
disabilities are available upon request.
Requests for such accommodations
should be submitted via email to
fcc504@fcc.gov or by calling the
Consumer & Governmental Affairs
Bureau at (202) 418–0530 (voice), (202)
418–0432 (tty). Such requests should
include a detailed description of the
accommodation needed. In addition,
please include a way the FCC can
contact you if it needs more
information. Please allow at least five
days’ advance notice; last-minute
requests will be accepted but may be
impossible to fill.
device, or any other electronic or
mechanical device designed for similar
purposes is prohibited at ASC meetings.
Dated: June 25, 2019.
James R. Park,
Executive Director.
[FR Doc. 2019–13912 Filed 6–27–19; 8:45 am]
BILLING CODE 6700–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare and Medicaid
Services
[CMS–3379–PN]
Federal Communications Commission.
Marlene Dortch,
Secretary.
Medicare and Medicaid Programs:
Application by Accreditation
Commission for Health Care for
Continued CMS-Approval of Its
Hospice Accreditation Program
[FR Doc. 2019–13785 Filed 6–27–19; 8:45 am]
AGENCY:
BILLING CODE 6712–01–P
FEDERAL FINANCIAL INSTITUTIONS
EXAMINATION COUNCIL
[Docket No. AS19–05]
Appraisal Subcommittee Notice of
Meeting
Appraisal Subcommittee of the
Federal Financial Institutions
Examination Council.
ACTION: Notice of Special Meeting.
AGENCY:
Description: In accordance with
Section 1104(b) of Title XI of the
Financial Institutions Reform, Recovery,
and Enforcement Act of 1989, as
amended, notice is hereby given that the
Appraisal Subcommittee (ASC) will
meet in open session for a Special
Meeting:
Location: Partnership for Public
Service, 1100 New York Avenue NW,
Suite 200 East, Room 2AB, Washington,
DC 20005.
Date: July 9, 2019.
Time: 10:00 a.m.
Status: Open.
Action and Discussion Items: North
Dakota Temporary Waiver Request.
How to Attend and Observe an ASC
meeting: If you plan to attend the ASC
Meeting in person, we ask that you send
an email to meetings@asc.gov. You may
register until close of business July 5,
2019. The meeting space is intended to
accommodate public attendees.
However, if the space will not
accommodate all requests, the ASC may
refuse attendance on that reasonable
basis. The use of any video or audio
tape recording device, photographing
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Centers for Medicare and
Medicaid Services, HHS.
ACTION: Proposed notice.
This proposed notice
acknowledges the receipt of an
application from the Accreditation
Commission for Health Care for
continued recognition as a national
accrediting organization for hospices
that wish to participate in the Medicare
or Medicaid programs. The statute
requires that within 60 days of receipt
of an organizations complete
application, the Centers for Medicare &
Medicaid Services publish a notice that
identifies the national accrediting body
making the request, describes the nature
of the request, and provides at least a
30-day public comment period.
DATES: To be assured consideration,
comments must be received at one of
the addresses provided below, no later
than 5 p.m. on July 30, 2019.
ADDRESSES: In commenting, please refer
to file code CMS–3379–PN. Because of
staff and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
Comments, including mass comment
submissions, must be submitted in one
of the following three ways (please
choose only one of the ways listed):
1. Electronically. You may submit
electronic comments on specific issues
in this regulation to https://
www.regulations.gov. Follow the
‘‘submit a comment’’ instructions.
2. By regular mail. You may mail
written comments to the following
address ONLY:
Centers for Medicare & Medicaid
Services, Department of Health and
Human Services, Attention: CMS–3379–
SUMMARY:
E:\FR\FM\28JNN1.SGM
28JNN1
Federal Register / Vol. 84, No. 125 / Friday, June 28, 2019 / Notices
PN, P.O. Box 8010, Baltimore, MD
21244–8010.
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments to the
following address ONLY:
Centers for Medicare & Medicaid
Services, Department of Health and
Human Services, Attention: CMS–3379–
PN, Mail Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
FOR FURTHER INFORMATION CONTACT:
Lillian Williams, (410) 786–8636.
Joy Webb, (410) 786–1667.
Karen Tritz, (410) 786–0821.
SUPPLEMENTARY INFORMATION: Inspection
of Public Comments: All comments
received before the close of the
comment period are available for
viewing by the public, including any
personally identifiable or confidential
business information that is included in
a comment. We post all comments
received before the close of the
comment period on the following
website as soon as possible after they
have been received: https://
www.regulations.gov. Follow the search
instructions on that website to view
public comments.
khammond on DSKBBV9HB2PROD with NOTICES
I. Background
Under the Medicare program, eligible
beneficiaries may receive covered
services in a hospice provided certain
requirements are met by the hospice.
Sections 1861(dd) of the Social Security
Act (the Act) establish distinct criteria
for facilities seeking designation as a
hospice. Regulations concerning
provider agreements are at 42 CFR part
489 and those pertaining to activities
related to the survey and certification of
facilities are at 42 CFR part 488. The
regulations at 42 CFR part 418, specify
the conditions that a hospice must meet
in order to participate in the Medicare
program, the scope of covered services
and the conditions for Medicare
payment for hospices.
Generally, to enter into an agreement,
a hospice must first be certified by a
State survey agency as complying with
the conditions or requirements set forth
in part 418. Thereafter, the hospice is
subject to regular surveys by a State
survey agency to determine whether it
continues to meet these requirements.
However, there is an alternative to
surveys by state agencies. Section
1865(a)(1) of the Act provides that, if a
provider entity demonstrates through
accreditation by an approved national
accrediting organization that all
applicable Medicare conditions are met
or exceeded, we will deem those
VerDate Sep<11>2014
17:41 Jun 27, 2019
Jkt 247001
provider entities as having met the
requirements. Accreditation by an
accrediting organization is voluntary
and is not required for Medicare
participation.
If an accrediting organization is
recognized by the Secretary of the
Department of Health and Human
Services as having standards for
accreditation that meet or exceed
Medicare requirements, any provider
entity accredited by the national
accrediting body’s approved program
would be deemed to meet the Medicare
conditions. A national accrediting
organization applying for deeming
authority under part 488, subpart A,
must provide us with reasonable
assurance that the accrediting
organization requires the accredited
provider entities to meet requirements
that are at least as stringent as the
Medicare conditions. Our regulations
concerning the reapproval of accrediting
organizations are set forth at § 488.5.
The regulations at § 488.5(e)(2)(i)
require accrediting organizations to
reapply for continued deeming
authority every 6 years or sooner as
determined by Centers for Medicare and
Medicaid Services (CMS).
The Accreditation Commission for
Health Care’s (ACHC’s) term of approval
for its hospice accreditation program
expires November 27, 2019.
II. Approval of Deeming Organizations
Section 1865(a)(2) of the Act and our
regulations at § 488.5 require that our
findings concerning review and
approval of a national accrediting
organization’s requirements consider,
among other factors, the applying
accrediting organization’s requirements
for accreditation; survey procedures;
resources for conducting required
surveys; capacity to furnish information
for use in enforcement activities;
monitoring procedures for provider
entities found not in compliance with
the conditions or requirements; and
ability to provide CMS with the
necessary data for validation.
Section 1865(a)(3)(A) of the Act
further requires that we publish, within
60 days of receipt of an organization’s
complete application, a notice
identifying the national accrediting
body making the request, describing the
nature of the request, and providing at
least a 30-day public comment period.
We have 210 days from the receipt of a
complete application to publish notice
of approval or denial of the application.
The purpose of this proposed notice
is to inform the public of ACHC’s
request for continued CMS approval of
its hospice accreditation program. This
notice also solicits public comment on
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
31069
whether ACHC’s requirements meet or
exceed the Medicare conditions for
participation for hospices.
III. Evaluation of Deeming Authority
Request
ACHC submitted all the necessary
materials to enable us to make a
determination concerning its request for
continued approval of its hospice
accreditation program. This application
was determined to be complete on May
1, 2019. Under Section 1865(a)(2) of the
Act and our regulations at § 488.5
(Application and re-application
procedures for national organizations),
our review and evaluation of ACHC will
be conducted in accordance with, but
not necessarily limited to, the following
factors:
• The equivalency of ACHC’s
standards for hospices as compared
with CMS’ hospice conditions of
participation.
• ACHC’s survey process to
determine the following:
++ ACHC’s composition of the survey
team, surveyor qualifications, and the
ability of the organization to provide
continuing surveyor training.
++ ACHC’s processes compared to
those of State agencies, including survey
frequency, and the ability to investigate
and respond appropriately to
complaints against accredited facilities.
++ ACHC’s processes and procedures
for monitoring a hospice found out of
compliance with ACHC’s program
requirements. These monitoring
procedures are used only when ACHC
identifies noncompliance. If
noncompliance is identified through
validation reviews, the State survey
agency monitors corrections as specified
at § 488.9(c).
++ ACHC’s capacity to report
deficiencies to the surveyed facilities
and respond to the facility’s plan of
correction in a timely manner.
++ ACHC’s capacity to provide CMS
with electronic data, and reports
necessary for effective validation and
assessment of the organization’s survey
process.
++ ACHC’s staff adequacy and other
resources, and its financial viability.
++ ACHC’s capacity to adequately
fund required surveys.
++ ACHC’s policies with respect to
whether surveys are announced or
unannounced to assure that surveys are
unannounced.
++ ACHC’s agreement to provide
CMS with a copy of the most current
accreditation survey together with any
other information related to the survey
as we may require (including corrective
action plans).
E:\FR\FM\28JNN1.SGM
28JNN1
31070
Federal Register / Vol. 84, No. 125 / Friday, June 28, 2019 / Notices
IV. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is reporting, recordkeeping and
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. chapter 35).
V. Response to Comments
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
able to acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble, and, when we proceed
with a subsequent document, we will
respond to the comments in the
preamble to that document.
Upon completion of our evaluation,
including evaluation of comments
received as a result of this notice, we
will publish a final notice in the Federal
Register announcing the result of our
evaluation.
Dated: June 11, 2019.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2019–13901 Filed 6–27–19; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–1728–N]
Medicare Program; Rechartering and
Appointment of New Members to the
Medicare Advisory Panel on Clinical
Diagnostic Laboratory Tests
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice announces the
rechartering and appointment of seven
new members to the Medicare Advisory
Panel on Clinical Diagnostic Laboratory
Tests (the CDLT Panel). The purpose of
the CDLT Panel is to advise the
Secretary of the Department of Health
and Human Services and the
Administrator of the Centers for
Medicare & Medicaid Services on issues
related to clinical diagnostic laboratory
tests.
DATES:
khammond on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:41 Jun 27, 2019
Jkt 247001
Recharter Dates: The charter for the
CDLT Panel will expire on April 26,
2021 (2 years from the date the charter
was filed).
New CDLT Panel Member
Appointment Dates: The term period for
the new CDLT Panel members is July 1,
2019 through June 30, 2022.
FOR FURTHER INFORMATION CONTACT:
Rasheeda Arthur, Ph.D., Designated
Federal Official (DFO), (410) 786–3434
or email at CDLTPanel@cms.hhs.gov.
Press inquiries are handled through
the CMS Press Office at (202) 690–6145.
For additional information on the
CDLT Panel, please refer to the CMS
website at https://www.cms.gov/
Regulations-and-Guidance/Guidance/
FACA/AdvisoryPanelonClinical
DiagnosticLaboratoryTests.html.
SUPPLEMENTARY INFORMATION:
I. Background
The Medicare Advisory Panel on
Clinical Diagnostic Laboratory Tests
(CDLT Panel) is authorized by section
1834A(f)(1) of the Social Security Act
(the Act) (42 U.S.C. 1395m–1), as
established by section 216(a) of the
Protecting Access to Medicare Act of
2014 (PAMA). (Pub. L. 113–93), enacted
on April 1, 2014. The CDLT Panel is
subject to the Federal Advisory
Committee Act (FACA), as amended (5
U.S.C. Appendix 2), which sets forth
standards for the formation and use of
advisory panels.
Section 1834A(f)(1) of the Act directs
the Secretary of the Department of
Health and Human Services (the
Secretary) to consult with an expert
outside advisory panel established by
the Secretary, composed of an
appropriate selection of individuals
with expertise in issues related to
clinical diagnostic laboratory tests.
Individuals may include molecular
pathologists, researchers, and
individuals with expertise in laboratory
science or health economics.
The CDLT Panel will provide
information and recommendations to
the Secretary and the Administrator of
the Center for Medicare & Medicaid
Services (CMS), on the following:
• The establishment of payment rates
under section 1834A of the Act for new
Clinical Diagnostic Laboratory Tests
(CDLTs), including whether to use
‘‘cross walking’’ or ‘‘gap filling’’
processes to determine payment for a
specific new test;
• The factors used in determining
coverage and payment processes for
new CDLTs; and
• Other aspects of the new payment
system under section 1834A of the Act.
A notice announcing the
establishment of the CDLT Panel and
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
soliciting nominations for members was
published in the October 27, 2014
Federal Register (79 FR 63919 through
63920). In the August 7, 2015 Federal
Register (80 FR 47491), we announced
membership appointments to the CDLT
Panel along with the first public
meeting date for the CDLT Panel, which
was held on August 26, 2015.
Subsequent meetings of the CDLT Panel
and membership appointments were
also announced in the Federal Register.
The CDLT Panel charter provides that
CDLT Panel meetings will be held up to
4 times annually and the CDLT Panel
shall consist of up to 15 individuals
appointed by the Secretary’s or CMS
Administrator’s designee to serve a term
of up to 3 years. Members may serve
after the expiration of his or her term
until a successor has been sworn-in. A
CDLT Panel member selected to replace
another CDLT Panel member who has
resigned prior to the end of his or her
term shall serve for the balance of the
original CDLT Panel members’ term.
II. Provisions of the Notice
A notice requesting nominations to
the CDLT Panel was published in the
September 29, 2017 Federal Register (82
FR 45590 through 45592). In that notice,
we stated that nominations would be
accepted on a continuous basis. Since
the last CDLT Panel meeting, which was
held July 16 through 17, 2018, the
Secretary’s designee approved
membership (term period: July 1, 2019
through June 30, 2022) of the following
new panel members (parenthetical
denotes nomination source(s)):
• Maria Arcila, MD (Memorial Sloan
Kettering Cancer Center);
• Karen Carroll, MD, FIDSA
(Infectious Diseases Society of America);
• Lydia Contis, MD (University of
Pittsburgh School of Medicine);
• Elizabeth Harris, MD (Humana,
Inc.);
• Kevin Krock, Ph.D. (Precision
Diagnostics);
• Elaine Lyon, Ph.D. (Association for
Molecular Pathologists);
• Heather Shappell, MS, CGC
(National Society of Genetic
Counselors);
Current CDLT Panel members
(parenthetical denotes nomination
source(s):
• Vickie Baselski, Ph.D. (American
Society of Microbiology);
• Aaron Bossler, M.D., Ph.D.
(Association for Molecular Pathologists);
• Pranil Chandra, D.O. (Association
for Molecular Pathologists);
• William Clarke, Ph.D., M.B.A.,
DABCC, FACB (American Association
of Clinical Chemistry);
• Stanley R. Hamilton, M.D. (Alliance
of Dedicated Cancer Centers; College of
E:\FR\FM\28JNN1.SGM
28JNN1
Agencies
[Federal Register Volume 84, Number 125 (Friday, June 28, 2019)]
[Notices]
[Pages 31068-31070]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-13901]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare and Medicaid Services
[CMS-3379-PN]
Medicare and Medicaid Programs: Application by Accreditation
Commission for Health Care for Continued CMS-Approval of Its Hospice
Accreditation Program
AGENCY: Centers for Medicare and Medicaid Services, HHS.
ACTION: Proposed notice.
-----------------------------------------------------------------------
SUMMARY: This proposed notice acknowledges the receipt of an
application from the Accreditation Commission for Health Care for
continued recognition as a national accrediting organization for
hospices that wish to participate in the Medicare or Medicaid programs.
The statute requires that within 60 days of receipt of an organizations
complete application, the Centers for Medicare & Medicaid Services
publish a notice that identifies the national accrediting body making
the request, describes the nature of the request, and provides at least
a 30-day public comment period.
DATES: To be assured consideration, comments must be received at one of
the addresses provided below, no later than 5 p.m. on July 30, 2019.
ADDRESSES: In commenting, please refer to file code CMS-3379-PN.
Because of staff and resource limitations, we cannot accept comments by
facsimile (FAX) transmission.
Comments, including mass comment submissions, must be submitted in
one of the following three ways (please choose only one of the ways
listed):
1. Electronically. You may submit electronic comments on specific
issues in this regulation to https://www.regulations.gov. Follow the
``submit a comment'' instructions.
2. By regular mail. You may mail written comments to the following
address ONLY:
Centers for Medicare & Medicaid Services, Department of Health and
Human Services, Attention: CMS-3379-
[[Page 31069]]
PN, P.O. Box 8010, Baltimore, MD 21244-8010.
Please allow sufficient time for mailed comments to be received
before the close of the comment period.
3. By express or overnight mail. You may send written comments to
the following address ONLY:
Centers for Medicare & Medicaid Services, Department of Health and
Human Services, Attention: CMS-3379-PN, Mail Stop C4-26-05, 7500
Security Boulevard, Baltimore, MD 21244-1850.
FOR FURTHER INFORMATION CONTACT:
Lillian Williams, (410) 786-8636.
Joy Webb, (410) 786-1667.
Karen Tritz, (410) 786-0821.
SUPPLEMENTARY INFORMATION: Inspection of Public Comments: All comments
received before the close of the comment period are available for
viewing by the public, including any personally identifiable or
confidential business information that is included in a comment. We
post all comments received before the close of the comment period on
the following website as soon as possible after they have been
received: https://www.regulations.gov. Follow the search instructions on
that website to view public comments.
I. Background
Under the Medicare program, eligible beneficiaries may receive
covered services in a hospice provided certain requirements are met by
the hospice. Sections 1861(dd) of the Social Security Act (the Act)
establish distinct criteria for facilities seeking designation as a
hospice. Regulations concerning provider agreements are at 42 CFR part
489 and those pertaining to activities related to the survey and
certification of facilities are at 42 CFR part 488. The regulations at
42 CFR part 418, specify the conditions that a hospice must meet in
order to participate in the Medicare program, the scope of covered
services and the conditions for Medicare payment for hospices.
Generally, to enter into an agreement, a hospice must first be
certified by a State survey agency as complying with the conditions or
requirements set forth in part 418. Thereafter, the hospice is subject
to regular surveys by a State survey agency to determine whether it
continues to meet these requirements.
However, there is an alternative to surveys by state agencies.
Section 1865(a)(1) of the Act provides that, if a provider entity
demonstrates through accreditation by an approved national accrediting
organization that all applicable Medicare conditions are met or
exceeded, we will deem those provider entities as having met the
requirements. Accreditation by an accrediting organization is voluntary
and is not required for Medicare participation.
If an accrediting organization is recognized by the Secretary of
the Department of Health and Human Services as having standards for
accreditation that meet or exceed Medicare requirements, any provider
entity accredited by the national accrediting body's approved program
would be deemed to meet the Medicare conditions. A national accrediting
organization applying for deeming authority under part 488, subpart A,
must provide us with reasonable assurance that the accrediting
organization requires the accredited provider entities to meet
requirements that are at least as stringent as the Medicare conditions.
Our regulations concerning the reapproval of accrediting organizations
are set forth at Sec. 488.5. The regulations at Sec. 488.5(e)(2)(i)
require accrediting organizations to reapply for continued deeming
authority every 6 years or sooner as determined by Centers for Medicare
and Medicaid Services (CMS).
The Accreditation Commission for Health Care's (ACHC's) term of
approval for its hospice accreditation program expires November 27,
2019.
II. Approval of Deeming Organizations
Section 1865(a)(2) of the Act and our regulations at Sec. 488.5
require that our findings concerning review and approval of a national
accrediting organization's requirements consider, among other factors,
the applying accrediting organization's requirements for accreditation;
survey procedures; resources for conducting required surveys; capacity
to furnish information for use in enforcement activities; monitoring
procedures for provider entities found not in compliance with the
conditions or requirements; and ability to provide CMS with the
necessary data for validation.
Section 1865(a)(3)(A) of the Act further requires that we publish,
within 60 days of receipt of an organization's complete application, a
notice identifying the national accrediting body making the request,
describing the nature of the request, and providing at least a 30-day
public comment period. We have 210 days from the receipt of a complete
application to publish notice of approval or denial of the application.
The purpose of this proposed notice is to inform the public of
ACHC's request for continued CMS approval of its hospice accreditation
program. This notice also solicits public comment on whether ACHC's
requirements meet or exceed the Medicare conditions for participation
for hospices.
III. Evaluation of Deeming Authority Request
ACHC submitted all the necessary materials to enable us to make a
determination concerning its request for continued approval of its
hospice accreditation program. This application was determined to be
complete on May 1, 2019. Under Section 1865(a)(2) of the Act and our
regulations at Sec. 488.5 (Application and re-application procedures
for national organizations), our review and evaluation of ACHC will be
conducted in accordance with, but not necessarily limited to, the
following factors:
The equivalency of ACHC's standards for hospices as
compared with CMS' hospice conditions of participation.
ACHC's survey process to determine the following:
++ ACHC's composition of the survey team, surveyor qualifications,
and the ability of the organization to provide continuing surveyor
training.
++ ACHC's processes compared to those of State agencies, including
survey frequency, and the ability to investigate and respond
appropriately to complaints against accredited facilities.
++ ACHC's processes and procedures for monitoring a hospice found
out of compliance with ACHC's program requirements. These monitoring
procedures are used only when ACHC identifies noncompliance. If
noncompliance is identified through validation reviews, the State
survey agency monitors corrections as specified at Sec. 488.9(c).
++ ACHC's capacity to report deficiencies to the surveyed
facilities and respond to the facility's plan of correction in a timely
manner.
++ ACHC's capacity to provide CMS with electronic data, and reports
necessary for effective validation and assessment of the organization's
survey process.
++ ACHC's staff adequacy and other resources, and its financial
viability.
++ ACHC's capacity to adequately fund required surveys.
++ ACHC's policies with respect to whether surveys are announced or
unannounced to assure that surveys are unannounced.
++ ACHC's agreement to provide CMS with a copy of the most current
accreditation survey together with any other information related to the
survey as we may require (including corrective action plans).
[[Page 31070]]
IV. Collection of Information Requirements
This document does not impose information collection requirements,
that is reporting, recordkeeping and third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. chapter 35).
V. Response to Comments
Because of the large number of public comments we normally receive
on Federal Register documents, we are not able to acknowledge or
respond to them individually. We will consider all comments we receive
by the date and time specified in the DATES section of this preamble,
and, when we proceed with a subsequent document, we will respond to the
comments in the preamble to that document.
Upon completion of our evaluation, including evaluation of comments
received as a result of this notice, we will publish a final notice in
the Federal Register announcing the result of our evaluation.
Dated: June 11, 2019.
Seema Verma,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2019-13901 Filed 6-27-19; 8:45 am]
BILLING CODE 4120-01-P